Source: FinSMEs

Maxion Therapeutics received $72M in Series A Funding

Read full article »

Maxion Therapeutics's Competitors | Maxion Therapeutics's News | Maxion Therapeutics's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

CEO

Arndt Schottelius

CEO Approval Rating

90/100

Maxion Therapeutics is an England-based biotechnology company that researches and develops protein therapeutics for the treatment of cancer and diabetes.